Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board to standardize ADDS quality‑assurance reporting after finding underreporting and inconsistent data
Summary
The enforcement committee reported continued underreporting of automated drug delivery system (ADDS) quality‑assurance records and recommended staff create outreach and a standardized reporting template to improve compliance and data quality for future evaluation.
The California State Board of Pharmacy’s Enforcement and Compounding Committee told the full board that quality‑assurance reports tied to automated drug delivery systems (ADDS) remain inconsistent and likely underreported, hampering the board’s ability to evaluate and respond to ADDS‑related medication errors.
Committee chair Maria Serpa summarized presentations and committee discussion noting the board submitted a legislative report as required and that BPC section 4427.8 and 16 CCR §1711(f) create ongoing ADDS QA reporting duties. The committee recommended staff pursue outreach, revise FAQs, and develop a standardized template to collect consistent data elements…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
